Pipeline Watch: Phase III Starts In Social Anxiety, Alopecia Areata And COVID-19

GSK/Vir's Sotrovimab Approved In US For COVID-19

 
• By John Davis
Pipeline Watch regular column feature image

More from Pipeline Watch

More from R&D